Lymphocyte-Specific Protein tyrosine Kinase (LCK) (N-Term) Peptide
Quick Overview for Lymphocyte-Specific Protein tyrosine Kinase (LCK) (N-Term) Peptide (ABIN8104635)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- LCK Peptide - N-terminal region
-
Sequence
- ENCHYPIVPL DGKGTLLIRN GSEVRDPLVT YEGSNPPASP LQDNLVIALH
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-LCK Antibody (ARP54524_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- LCK (Lymphocyte-Specific Protein tyrosine Kinase (LCK))
-
Background
- LCK is a member of the Src family of protein tyrosine kinases (PTKs). It is a key signaling molecule in the selection and maturation of developing T-cells. It contains N-terminal sites for myristylation and palmitylation, a PTK domain, and SH2 and SH3 domains which are involved in mediating protein-protein interactions with phosphotyrosine-containing and proline-rich motifs, respectively. LCK localizes to the plasma membrane and pericentrosomal vesicles, and binds to cell surface receptors, including CD4 and CD8, and other signaling molecules.
-
Molecular Weight
- 39kDa
-
Gene ID
- 3932
-
UniProt
- P06239
Target
-